• Immunogen Inc., of Waltham, Mass., reported a net loss of $11.2 million, or 13 cents per basic and diluted share during its 2014 first quarter ending Sept. 30, compared to a net loss of $25.2 million, or 30 cents per basic and diluted share, for the same quarter in the previous year. Revenues for the quarter were $17.2 million, compared to $4.1 million during the same quarter a year earlier, and included $13.2 million in license and milestone fees compared to $900,000 in the same quarter a year earlier.